Cargando…
Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis
Multiple myeloma (MM) is a common hematologic malignancy for which the underlying molecular mechanisms remain largely unclear. This study aimed to elucidate key candidate genes and pathways in MM by integrated bioinformatics analysis. Expression profiles GSE6477 and GSE47552 were obtained from the G...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771956/ https://www.ncbi.nlm.nih.gov/pubmed/31215027 http://dx.doi.org/10.1002/jcp.28947 |
_version_ | 1783455802246299648 |
---|---|
author | Yan, Haimeng Zheng, Gaofeng Qu, Jianwei Liu, Yang Huang, Xi Zhang, Enfan Cai, Zhen |
author_facet | Yan, Haimeng Zheng, Gaofeng Qu, Jianwei Liu, Yang Huang, Xi Zhang, Enfan Cai, Zhen |
author_sort | Yan, Haimeng |
collection | PubMed |
description | Multiple myeloma (MM) is a common hematologic malignancy for which the underlying molecular mechanisms remain largely unclear. This study aimed to elucidate key candidate genes and pathways in MM by integrated bioinformatics analysis. Expression profiles GSE6477 and GSE47552 were obtained from the Gene Expression Omnibus database, and differentially expressed genes (DEGs) with p < .05 and [logFC] > 1 were identified. Functional enrichment, protein–protein interaction network construction and survival analyses were then performed. First, 51 upregulated and 78 downregulated DEGs shared between the two GSE datasets were identified. Second, functional enrichment analysis showed that these DEGs are mainly involved in the B cell receptor signaling pathway, hematopoietic cell lineage, and NF‐kappa B pathway. Moreover, interrelation analysis of immune system processes showed enrichment of the downregulated DEGs mainly in B cell differentiation, positive regulation of monocyte chemotaxis and positive regulation of T cell proliferation. Finally, the correlation between DEG expression and survival in MM was evaluated using the PrognoScan database. In conclusion, we identified key candidate genes that affect the outcomes of patients with MM, and these genes might serve as potential therapeutic targets. |
format | Online Article Text |
id | pubmed-6771956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67719562019-10-07 Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis Yan, Haimeng Zheng, Gaofeng Qu, Jianwei Liu, Yang Huang, Xi Zhang, Enfan Cai, Zhen J Cell Physiol Original Research Articles Multiple myeloma (MM) is a common hematologic malignancy for which the underlying molecular mechanisms remain largely unclear. This study aimed to elucidate key candidate genes and pathways in MM by integrated bioinformatics analysis. Expression profiles GSE6477 and GSE47552 were obtained from the Gene Expression Omnibus database, and differentially expressed genes (DEGs) with p < .05 and [logFC] > 1 were identified. Functional enrichment, protein–protein interaction network construction and survival analyses were then performed. First, 51 upregulated and 78 downregulated DEGs shared between the two GSE datasets were identified. Second, functional enrichment analysis showed that these DEGs are mainly involved in the B cell receptor signaling pathway, hematopoietic cell lineage, and NF‐kappa B pathway. Moreover, interrelation analysis of immune system processes showed enrichment of the downregulated DEGs mainly in B cell differentiation, positive regulation of monocyte chemotaxis and positive regulation of T cell proliferation. Finally, the correlation between DEG expression and survival in MM was evaluated using the PrognoScan database. In conclusion, we identified key candidate genes that affect the outcomes of patients with MM, and these genes might serve as potential therapeutic targets. John Wiley and Sons Inc. 2019-06-18 2019-12 /pmc/articles/PMC6771956/ /pubmed/31215027 http://dx.doi.org/10.1002/jcp.28947 Text en © 2019 The Authors. Journal of Cellular Physiology Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Articles Yan, Haimeng Zheng, Gaofeng Qu, Jianwei Liu, Yang Huang, Xi Zhang, Enfan Cai, Zhen Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis |
title | Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis |
title_full | Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis |
title_fullStr | Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis |
title_full_unstemmed | Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis |
title_short | Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis |
title_sort | identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771956/ https://www.ncbi.nlm.nih.gov/pubmed/31215027 http://dx.doi.org/10.1002/jcp.28947 |
work_keys_str_mv | AT yanhaimeng identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis AT zhenggaofeng identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis AT qujianwei identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis AT liuyang identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis AT huangxi identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis AT zhangenfan identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis AT caizhen identificationofkeycandidategenesandpathwaysinmultiplemyelomabyintegratedbioinformaticsanalysis |